The scope of the proposed program includes manufacture of sabin?S sudan ebolavirus vaccine (bulk drug substance (BDS) and final drug product (FDP)) to provide doses that may be used in the event of an…

Active Definitive Contract Awarded Last action

Contract number
75A50123C00010
Awardee
Awarding agency
Obligated
$158,810,481

Award facts

Opportunity
Contract value 67% obligated
  • $158,810,480.65 Current, with exercised options
  • $238,381,725.66 Potential, with all options
Completion date 50% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Washington, DC 20037, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00012 · The purpose of this modification is to 1. Exercise option period 2 clin 0003 with a period of performance of july 22, 2025, to december 28, 2032, in the… $38,697,184
Supplemental Agreement for work within scope P00011 · The purpose of this modification is as follows: 1. Clin 0008 (option 7) the total unexercised value is hereby decreased from $8,443,038.00 by $1,554,748.99 to… $1,554,749
Supplemental Agreement for work within scope P00010 · The purpose of this modification is as follows: 1. Clin 0001/ base: increase the funding from $52,015,534.00 by $4,695,621.32 to $56,711,155.32 to facilitate… $13,081,212
Supplemental Agreement for work within scope P00009 · The purpose of this no cost modification is to donate 188 vials of sudv clinical trial material for three nonclinical studies as follows: 1. Clin 0001 (base… $0
Supplemental Agreement for work within scope P00008 · The purpose of this modification is hereby amended as follows: 1. Clin 0001 (base period) is hereby amended as follows: a. An additional $17,053,156 in funds… $17,053,156
Supplemental Agreement for work within scope P00007 · The purpose of this no cost modification is to add an audit of reithera SRL to the scope of clin 0005 as follows: 1. Clin 0005 (option 4) is hereby amended as… $0
Supplemental Agreement for work within scope P00006 · The purpose of this modification is to change production under clin 0005 and clin 0006 and extend the period of performance on clin 0005 as follows: 1. Clin… $17,034,066
Supplemental Agreement for work within scope P00005 · The purpose of this no cost modification is to incorporate an updated statement of work amending the verbiage as follows: 1. Clin 0001 is hereby amended perform… $0
Supplemental Agreement for work within scope P00004 · The purpose of this $0 modification is to: 1. Clin 0001 is hereby amended to include an additional 4TH DS batch run of sudv, and to reflect the increase of… $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Exercise an Option P00001 $36,427,736
Original award $34,962,378
Show all 13

About this award

Written by GovTribe AI ·

This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Albert B. Sabin Vaccine Institute, Inc. for the manufacture of the Sabin's Sudan Ebolavirus vaccine. The contract has a period of performance from July 22, 2025 to December 28, 2032 and a ceiling value of $238,381,725.66. It is a Cost Plus Fixed Fee contract, with no set-aside designation. The contract was originally solicited through a Broad Agency Announcement (BAA) from the Biomedical Advanced Research and Development Authority (BARDA) seeking proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats. The purpose of this contract is to provide doses of the Sabin's Sudan Ebolavirus vaccine that may be used in the event of an outbreak.

Description

As the agency reported it.

The scope of the proposed program includes manufacture of sabin?S sudan ebolavirus vaccine (bulk drug substance (BDS) and final drug product (FDP)) to provide doses that may be used in the event of an outbreak scenario. The proposed effort will utili

Subawards

Subcontractor Amount Awarded
Arranta Bio Ma LLC THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $1,370,500
Biologics Consulting Group, Inc. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $219,375
Syneos Health LLC THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $30,720
Biologics Consulting Group, Inc. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $376,000
Reithera S.R.L. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $2,369,000
Reithera S.R.L. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $474,000
BDO Usa, P.C. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $398,000
Reithera S.R.L. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $10,700,000
Subcontractor not on record THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $365,766
Subcontractor not on record THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $458,526
Reithera S.R.L. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $11,050,000
BDO Usa, P.C. THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $398,000
Subcontractor not on record THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE… $365,766
Show all 13

Quick answers

Who was awarded contract 75A50123C00010?

75A50123C00010 was awarded to Albert B. Sabin Vaccine Institute, Inc. (The) by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on December 29, 2022.

How much is contract 75A50123C00010 worth?

The government has obligated $158,810,481 on 75A50123C00010. Its potential value, with all options, is $238,381,726.

Was contract 75A50123C00010 competed?

The extent of competition for 75A50123C00010 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login